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p53 Inactivation May Be Linked to Appearance of Solid Component in Lung Adenocarcinoma

Adenocarcinomas With Predominant Ground-Glass Opacity: Correlation of Morphology and Molecular Biomarkers.
Aoki T, Hanamiya M, et al: Radiology 2012; 264 (August): 590-596 p53 inactivation may be linked to new demonstration of a solid component in lung ground-glass opacity adenocarcinomas.
Background: Epidermal growth factor receptor (EGFR) and K-ras are the most often mutated oncogenes in lung adenocarcinoma. It is thought that these mutated oncogenes are involved in tumor cell proliferation, differentiation, and angiogenesis. p53, a tumor suppressor, can be inactivated by missense mutations and can be a cause of tumorigenesis or metastasis. According to the authors, it has been suggested that nuclear p53 accumulation occurs in the transition from early to more advanced stage adenocarcinoma, and this may be a good indicator of tumor malignancy. Objective: To correlate temporal changes in peripheral lung adenocarcinoma with dominant ground-glass opacity (GGO) as seen on CT with biomolecular markers. Design: Retrospective review. Participants: 25 patients who had lung adenocarcinoma and had undergone tumor resection. All tumors were <3 cm, and the GGO component of the tumor was >50% of the tumor size. Methods: The initial CTs and final CTs before surgery were evaluated for changes in size and morphology of the tumor. All tumors were characterized as either pure GGO or mixed GGO. Molecular analyses using genomic DNA from the surgical tumor specimens were performed. Results: In 19 of 25 (76%) patients, tumor size increased on successive CT. Of these 19 patients, 8 had tumors that were pure GGO and had greater GGO on follow-up, 3 had tumors that were pure GGO but were mixed GGO on follow-up, 4 had mixed GGO that had growth of the solid component on follow-up, and 4 had mixed GGO with growth of the GGO component on follow-up. In the 6 tumors (24%) that did not demonstrate any interval growth, all 6 were pure GGO that remained stable. p53 staining was negative in 14 of 14 (100%) pure GGO lesions. p53 staining was positive in 6 of 11 (55%) patients with mixed GGO (P <0.01). In all 6 of these patients, the appearance or growth of a solid component on CT was seen. In both pure (36%) and mixed (45%) GGO tumors, EGFR mutations were present. This difference was not statistically significant. Conclusions: p53 inactivation may be linked to new demonstration of a solid component in lung GGO adenocarcinomas. Reviewer's Comments: This is a very nice article that provides a strong argument to the authors' conclusions and is something that radiologists rarely think about. (Reviewer-Vineet R. Jain, MD). Internal medicine-trained physicians are more likely to follow established guidelines for filter placement when compared to physicians trained in other specialties.
Background:
In the United States, inferior vena cava (IVC) filters are placed by interventional radiologists (IR), vascular surgeons (VS), and interventional cardiologists (IC). A fair degree of self-referral is seen among providers. The American College of Chest Physicians (ACCP) and the Society of Interventional Radiology (SIR) have guidelines regarding filter placement with the SIR guideline being less stringent. Objective: To determine if guidelines regarding IVC filter placement are being followed across the spectrum of specialties providing IVC filter placement. Design: Retrospective single-center review of the medical records from a metropolitan acute-care teaching hospital. Methods: The study was performed over a period of 26 months with a total of 499 filters placed. The specialty of the referring provider, adherence to guideline criteria, and other factors were recorded and then evaluated. Results: Compliance with the more rigorous ACCP guidelines was moderate overall. Of the filters placed, 43.5% by IR staff, 39.9% by VS staff, and 33.3% by IC staff met the ACCP guidelines. Compliance with the SIR criteria was higher (77.5% by IR staff, 77.1% by VS staff, and 80% by IC staff). The self-referral rates among vascular surgery and interventional cardiology were 12% and 67%, respectively. When internal medicine-trained physicians requested a filter, there was a greater degree of ACCP criteria compliance (46.3%) compared to non-internal medicine-trained physicians (24.0%).
Conclusions:
There is poor compliance with IVC filter placement guidelines, especially when the patient is not directly referred by an internal medicine-trained physician. Reviewer's Comments: A true consensus to the criteria for filter placement is warranted based on the results of this study. Filter placement carries a risk of morbidity, and judicious use of this tool is important. Continuous monitoring of criteria adherence will likely improve patient outcomes and safety. I look forward to future guidelines that would clarify when IVC filters are needed. (Reviewer-Waseem A. Bhatti, MD, MS).
Radiofrequency Wire for the Recanalization of Central Vein Occlusions That Have Failed Conventional Endovascular
Techniques. A new radiofrequency guidewire shows early promise for crossing central venous occlusions.
Background: Central venous occlusions (CVOs) in cases such as super vena cava syndrome present challenges from crossing the lesions with a wire to stenting. A new wire with a radiofrequency (RF) tip can assist the operator in crossing these difficult occlusions.
Objective: To report the technique and review results of recanalization of CVOs using the PowerWire RF Guidewire.
Methods:
The authors completed a retrospective study of 42 symptomatic patients who underwent RF wire recanalization of 43 CVOs over a period of almost 4 years at a single center. All of the patients underwent stenting of these occlusive lesions during the same session. Six of the CVOs were located in the subclavian vein, 29 in the brachiocephalic vein, and 8 in the superior vena cava (SVC) vein. After failure of conventional endovascular techniques, the RF guidewire was used to cross central venous occlusions a few millimeters at a time while using a loop snare as a target and monitoring the position on multiple oblique fluoroscopic views. Results: Using the RF wire technique, the success rate was 100%. There was 1 major complication, which was a pericardial tamponade that occured during angioplasty of an SVC stent and likely not directly related to the RF wire. Forty of the 42 patients (95%) had patent stents and were asymptomatic at 6 and 9 months. Conclusions: According to the authors, "...the RF wire technique is a safe and efficient alternative in the recanalization of symptomatic and chronic CVOs when conventional endovascular techniques have failed." Reviewer's Comments: The RF guidewire is an exciting new device in the interventionalists' toolbox that shows early promise in this study. As with any new technology, novel applications lead to the ability to treat patients who would have otherwise had limited options. A head-to-head comparison with the complication rates of other occlusion crossing techniques and devices would be of interest. (Reviewer-Waseem A. Bhatti, MD, MS).
